Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.010 AlteredExpression disease BEFREE Genetically blocking apoptosis by over-expressing BCL2 ameliorates muscle weakness in our mouse model of OPMD (A17 mice). 21199860 2011
Entrez Id: 100529063
Gene Symbol: BCL2L2-PABPN1
BCL2L2-PABPN1
0.100 GeneticVariation disease CLINVAR
Entrez Id: 100529063
Gene Symbol: BCL2L2-PABPN1
BCL2L2-PABPN1
0.100 CausalMutation disease CLINVAR
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.010 Biomarker disease BEFREE A similar effect on β-catenin was also observed when lymphoblastoid cells lines (LCLs) derived from OPMD patients were treated with LiCl. 24091664 2013
Entrez Id: 3301
Gene Symbol: DNAJA1
DNAJA1
0.010 Biomarker disease LHGDN Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy. 11796717 2002
Entrez Id: 10049
Gene Symbol: DNAJB6
DNAJB6
0.010 Biomarker disease BEFREE Our data suggest that over-expression of MLF1 has no significant impact on skeletal muscle function in mice; that progressive formation of protein aggregates in muscle are not necessarily pathogenic; and that MLF1 and MRJ may function together to ameliorate the toxic effects of polyglutamine or mutant proteins in myodegenerative diseases such as inclusion body myositis and oculopharyngeal muscular dystrophy, as well as neurodegenerative disease. 17854834 2008
Entrez Id: 2280
Gene Symbol: FKBP1A
FKBP1A
0.010 Biomarker disease BEFREE In addition, CUGBP1, SFRS3, and FKBP1A were also found in OPMD muscle INIs. 15755682 2005
Entrez Id: 25801
Gene Symbol: GCA
GCA
0.010 GeneticVariation disease BEFREE PABPN1 genotyping and DNA sequence analysis revealed a heterozygous (GCG)10(GCA)3GCG mutation that led to the diagnosis of OPMD. 30412104 2018
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 GeneticVariation disease BEFREE Short GCG expansions in the poly(A) binding protein 2 (PABP2) gene were identified recently as the molecular basis for OPMD in French-Canadians. 10508991 1999
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 Biomarker disease BEFREE To answer this question, we examined five patients with the clinical characteristics of oculopharyngodistal myopathy for GCG expansion in poly(A)-binding protein nuclear 1 gene (previously called poly(A)-binding protein 2), the causative gene defect for oculopharyngeal muscular dystrophy. 11595511 2001
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 GeneticVariation disease BEFREE Oculopharyngeal muscular dystrophy (OPMD) is caused by short expansions of the GCG trinucleotide repeat encoding the polyalanine tract of the poly(A)-binding protein 2 (PABP2). 11371506 2001
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 GeneticVariation disease BEFREE Patients with the adult onset autosomal dominant OPMD (oculopharyngeal muscular dystrophy) carry the GCG expansion mutation in their PABPN1 gene. 22519734 2012
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 Biomarker disease BEFREE Since OPMD derives from a very small expansion of GCG within the polyAla tract, our hhRz and miRNA molecules cannot distinguish between the wild-type and mutant mRNAs of PABPN1. 30831428 2019
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 GeneticVariation disease BEFREE To independently confirm the presence and study the meiotic stability of the GCG expansion mutations in a distinct ethnic population with OPMD. 10555658 1999
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 Biomarker disease BEFREE OPMD is caused by short GCG repeat expansions within the gene encoding the nuclear poly(A)-binding protein 1 (PABPN1) that extend an N-terminal polyalanine tract in the protein. 16642034 2006
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 Biomarker disease BEFREE We diagnosed OPMD in 16 German patients by the detection of GCG repeat expansions, confirming genetic homogeneity. 11150975 2001
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 GeneticVariation disease BEFREE Here we exclude an expansion of the GCG repeat or any other mutation in the coding region of the PABPN1 gene (responsible for OPMD) in patients with AR oculopharyngodistal myopathy. 15377709 2004
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 GeneticVariation disease BEFREE Autosomal dominant OPMD is caused by a (GCG)8-13 repeat expansion in the polyadenylation binding protein 2 (PABP2) gene. 11087766 2000
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 Biomarker disease BEFREE GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy. 10680791 2000
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.100 GeneticVariation disease BEFREE The above results suggest that mutated GCG repeats in PABPN1 gene may cause OPMD in this family, and PABPN1 genotyping could be used as a convenient, highly effective, and reliable gene diagnostic test for OPMD patients. 21089175 2010
Entrez Id: 3178
Gene Symbol: HNRNPA1
HNRNPA1
0.010 Biomarker disease LHGDN HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy. 12945950 2003
Entrez Id: 3181
Gene Symbol: HNRNPA2B1
HNRNPA2B1
0.010 Biomarker disease LHGDN HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy. 12945950 2003
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.010 Biomarker disease BEFREE Overall, our data suggest a key role of <i>let-7</i> in the regeneration and degeneration process in OPMD muscle and pointed to IL-6 as a potential target molecule for new therapeutic approaches for this disorder.-Cappelletti, C., Galbardi, B., Bruttini, M., Salerno, F., Canioni, E., Pasanisi, M. B., Rodolico, C., Brizzi, T., Mora, M., Renieri, A., Maggi, L., Bernasconi, P., Mantegazza, R. Aging-associated genes and <i>let-7</i> microRNAs: a contribution to myogenic program dysregulation in oculopharyngeal muscular dystrophy. 30860873 2019
Entrez Id: 29967
Gene Symbol: LRP12
LRP12
0.300 Biomarker disease CTD_human Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. 31332380 2019
Entrez Id: 4054
Gene Symbol: LTBP3
LTBP3
0.010 GeneticVariation disease BEFREE Hindi version of the DASS-21 questionnaire appears to be culturally appropriate, reliable, and psychometrically valid tool for evaluation of the psychological burden (depression, anxiety, and stress) in Hindi-speaking HNC and OPMD patients. 31169235 2019